In vivo CRISPR screens in Head and Neck Cancer reveal that Uchl5 modulates extracellular matrix deposition to promote immune evasion [in vitro]
RNA-seq (gene expression) · mouse · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Mus musculus (mouse)
- Samples
- 12 samples: 3 × RNA-seq, MOC1-esc1 in vitro, sgCtrl, DMSO, vs 3 × RNA-seq, MOC1-esc1 in vitro, sgCtrl, IFNg, vs 3 × RNA-seq, MOC1-esc1 in vitro, sgUchl5, DMSO, vs 3 × RNA-seq, MOC1-esc1 in vitro, sgUchl5, IFNg,Groups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE269444_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1121934 and SRA study SRP512792. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8315894 RNA-seq, MOC1-esc1 in vitro, sgCtrl, DMSO, Replicate 1 RNA-seq, MOC1-esc1 in v…
- GSM8315895 RNA-seq, MOC1-esc1 in vitro, sgCtrl, DMSO, Replicate 2 RNA-seq, MOC1-esc1 in v…
- GSM8315896 RNA-seq, MOC1-esc1 in vitro, sgCtrl, DMSO, Replicate 3 RNA-seq, MOC1-esc1 in v…
- GSM8315897 RNA-seq, MOC1-esc1 in vitro, sgCtrl, IFNg, Replicate 1 RNA-seq, MOC1-esc1 in v…
- GSM8315898 RNA-seq, MOC1-esc1 in vitro, sgCtrl, IFNg, Replicate 2 RNA-seq, MOC1-esc1 in v…
- GSM8315899 RNA-seq, MOC1-esc1 in vitro, sgCtrl, IFNg, Replicate 3 RNA-seq, MOC1-esc1 in v…
- GSM8315900 RNA-seq, MOC1-esc1 in vitro, sgUchl5, DMSO, Replicate 1 RNA-seq, MOC1-esc1 in v…
- GSM8315901 RNA-seq, MOC1-esc1 in vitro, sgUchl5, DMSO, Replicate 2 RNA-seq, MOC1-esc1 in v…
- GSM8315902 RNA-seq, MOC1-esc1 in vitro, sgUchl5, DMSO, Replicate 3 RNA-seq, MOC1-esc1 in v…
- GSM8315903 RNA-seq, MOC1-esc1 in vitro, sgUchl5, IFNg, Replicate 1 RNA-seq, MOC1-esc1 in v…
- GSM8315904 RNA-seq, MOC1-esc1 in vitro, sgUchl5, IFNg, Replicate 2 RNA-seq, MOC1-esc1 in v…
- GSM8315905 RNA-seq, MOC1-esc1 in vitro, sgUchl5, IFNg, Replicate 3 RNA-seq, MOC1-esc1 in v…
- GSE269446 In vivo CRISPR screens in Head and Neck Cancer reveal that Uchl5 modulates extracellular matrix deposition to promote immune evasion 23 samples shares crispr, uchl5, extracellular, deposition, modulates, screens, promote, evasion
- GSE269445 In vivo CRISPR screens in Head and Neck Cancer reveal that Uchl5 modulates extracellular matrix deposition to promote immune evasion [in vivo] 11 samples shares crispr, uchl5, extracellular, deposition, modulates, screens, promote, evasion
- GSE338899 In vivo CRISPR screens identify dual functions of DNMT3A in mediating tumor immune evasion 12 samples shares crispr, screens, evasion
- GSE334845 Discovery of Tcf7 regulators with clonally-resolved CRISPR screens identifies Trim28 as a mediator of CD8 T cell differentiation in tumors [RNA-Seq] 86 samples shares crispr, screens
- GSE268044 StealTHY: enabling CRISPR-Cas9 screens in immunocompetent hosts to expose concealed metastatic regulators [single-end] 45 samples shares crispr, screens
- GSE220556 In vivo CRISPR screens reveal SCAF1 and USP15 as novel drivers of pancreatic cancer 20 samples shares crispr, screens
- GSE249759 In vivo CRISPR screens identify Mga as an immunotherapy target in triple-negative breast cancer 12 samples shares crispr, screens
- GSE306058 scCRISPR screens of CD8⁺ T cells in young vs. aged tumors and tdLNs 11 samples shares crispr, screens
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.